- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00085332
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
A Phase II Evaluation of Weekly Docetaxel (NSC #628503) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well docetaxel works in treating patients with recurrent or persistent endometrial carcinoma (cancer).
Panoramica dello studio
Descrizione dettagliata
OBJECTIVES:
- Determine the antitumor activity of docetaxel in patients with recurrent or persistent endometrial carcinoma.
- Determine the toxicity of this drug in these patients.
OUTLINE: This is a multicenter study.
Patients receive docetaxel IV over 1 hour on days 1, 8, and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Patients are followed every 3 months for 2 years and then every 6 months for 3 years.
PROJECTED ACCRUAL: A total of 19-51 patients will be accrued for this study within 10-18 months.
Tipo di studio
Fase
- Fase 2
Contatti e Sedi
Luoghi di studio
-
-
New South Wales
-
Camperdown, New South Wales, Australia, 1450
- Australia New Zealand Gynaecological Oncology Trials Group
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4N2
- Tom Baker Cancer Centre - Calgary
-
-
-
-
-
Kagoshima City, Giappone, 892-8580
- Kagoshima City Hospital
-
-
-
-
-
Oslo, Norvegia, N-0310
- Norwegian Radium Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, Stati Uniti, 35294-3300
- Comprehensive Cancer Center at University of Alabama at Birmingham
-
-
Arizona
-
Phoenix, Arizona, Stati Uniti, 85006-2726
- CCOP - Western Regional, Arizona
-
-
California
-
Los Angeles, California, Stati Uniti, 90095-1740
- Jonsson Comprehensive Cancer Center at UCLA
-
Los Gatos, California, Stati Uniti, 95032
- Women's Cancer Center - Los Gatos
-
Orange, California, Stati Uniti, 92868
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
-
-
Colorado
-
Denver, Colorado, Stati Uniti, 80010
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
-
-
Connecticut
-
New Haven, Connecticut, Stati Uniti, 06520-8028
- Yale Comprehensive Cancer Center
-
-
Delaware
-
Newark, Delaware, Stati Uniti, 19713
- CCOP - Christiana Care Health Services
-
-
District of Columbia
-
Washington, District of Columbia, Stati Uniti, 20307-5001
- Walter Reed Army Medical Center
-
-
Florida
-
Tampa, Florida, Stati Uniti, 33612-9497
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
-
-
Hawaii
-
Honolulu, Hawaii, Stati Uniti, 96813
- MBCCOP - Hawaii
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60637-1470
- University of Chicago Cancer Research Center
-
Chicago, Illinois, Stati Uniti, 60612
- MBCCOP - University of Illinois at Chicago
-
Chicago, Illinois, Stati Uniti, 60612-3824
- Rush University Medical Center
-
Decatur, Illinois, Stati Uniti, 62794-9640
- CCOP - Central Illinois
-
Evanston, Illinois, Stati Uniti, 60201
- CCOP - Evanston
-
Urbana, Illinois, Stati Uniti, 61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
Indianapolis, Indiana, Stati Uniti, 46202-5289
- Indiana University Cancer Center
-
South Bend, Indiana, Stati Uniti, 46617
- Saint Joseph Regional Medical Center
-
-
Iowa
-
Iowa City, Iowa, Stati Uniti, 52242-1002
- Holden Comprehensive Cancer Center at University of Iowa
-
-
Kentucky
-
Lexington, Kentucky, Stati Uniti, 40536-0084
- Markey Cancer Center at University of Kentucky Chandler Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02111
- Cancer Center at Tufts - New England Medical Center
-
Worcester, Massachusetts, Stati Uniti, 01605-2982
- UMASS Memorial Cancer Center - University Campus
-
-
Michigan
-
Ann Arbor, Michigan, Stati Uniti, 48106
- CCOP - Michigan Cancer Research Consortium
-
Grand Rapids, Michigan, Stati Uniti, 49503
- CCOP - Grand Rapids
-
Kalamazoo, Michigan, Stati Uniti, 49007-3731
- CCOP - Kalamazoo
-
-
Minnesota
-
Minneapolis, Minnesota, Stati Uniti, 55455
- University of Minnesota Cancer Center
-
Rochester, Minnesota, Stati Uniti, 55905-0001
- Mayo Clinic Cancer Center
-
Saint Louis Park, Minnesota, Stati Uniti, 55416
- CCOP - Metro-Minnesota
-
-
Mississippi
-
Jackson, Mississippi, Stati Uniti, 39216-4505
- University of Mississippi Medical Center
-
Keesler AFB, Mississippi, Stati Uniti, 39534-2576
- Keesler Medical Center - Keesler Air Force Base
-
-
Missouri
-
Columbia, Missouri, Stati Uniti, 65203
- Ellis Fischel Cancer Center at University of Missouri - Columbia
-
Kansas City, Missouri, Stati Uniti, 64131
- CCOP - Kansas City
-
Saint Louis, Missouri, Stati Uniti, 63110
- Siteman Cancer Center at Barnes-Jewish Hospital
-
Springfield, Missouri, Stati Uniti, 65807
- CCOP - Cancer Research for the Ozarks
-
-
Nebraska
-
Omaha, Nebraska, Stati Uniti, 68106
- CCOP - Missouri Valley Cancer Consortium
-
-
New Jersey
-
Camden, New Jersey, Stati Uniti, 08103-1489
- Cancer Institute of New Jersey at the Cooper University Hospital
-
-
New York
-
Brooklyn, New York, Stati Uniti, 11203
- SUNY Downstate Medical Center
-
Buffalo, New York, Stati Uniti, 14263-0001
- Roswell Park Cancer Institute
-
Manhasset, New York, Stati Uniti, 11030
- North Shore University Hospital
-
New York, New York, Stati Uniti, 10021
- Memorial Sloan-Kettering Cancer Center
-
Stony Brook, New York, Stati Uniti, 11790-7775
- Long Island Cancer Center at Stony Brook University Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, Stati Uniti, 27599-7570
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
-
Durham, North Carolina, Stati Uniti, 27710
- Duke Comprehensive Cancer Center
-
Greenville, North Carolina, Stati Uniti, 27858
- Gynecologic Oncology Network
-
Winston-Salem, North Carolina, Stati Uniti, 27157-1065
- Comprehensive Cancer Center at Wake Forest University
-
-
Ohio
-
Cincinnati, Ohio, Stati Uniti, 45267-0520
- Charles M. Barrett Cancer Center at University Hospital
-
Cleveland, Ohio, Stati Uniti, 44124
- Cleveland Clinic Taussig Cancer Center
-
Cleveland, Ohio, Stati Uniti, 44106
- Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University
-
Columbus, Ohio, Stati Uniti, 43210-1240
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stati Uniti, 73104
- University of Oklahoma College of Medicine
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97225
- CCOP - Columbia River Oncology Program
-
-
Pennsylvania
-
Abington, Pennsylvania, Stati Uniti, 19001-3788
- Abington Memorial Hospital
-
Danville, Pennsylvania, Stati Uniti, 17822-2001
- CCOP - Geisinger Clinic and Medical Center
-
Hershey, Pennsylvania, Stati Uniti, 17033-0850
- Penn State Cancer Institute at Milton S. Hershey Medical Center
-
Philadelphia, Pennsylvania, Stati Uniti, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Stati Uniti, 19104-4283
- Abramson Cancer Center of the University of Pennsylvania
-
Philadelphia, Pennsylvania, Stati Uniti, 19107
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
-
Pittsburgh, Pennsylvania, Stati Uniti, 15213-3180
- UPMC Cancer Center at Magee-Womens Hospital
-
-
Tennessee
-
Knoxville, Tennessee, Stati Uniti, 37917
- Southeast Gynecologic Oncology Associates
-
Nashville, Tennessee, Stati Uniti, 37232-2516
- Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
-
-
Texas
-
Dallas, Texas, Stati Uniti, 75390-9032
- Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas
-
Galveston, Texas, Stati Uniti, 77555-0587
- University of Texas Medical Branch
-
Houston, Texas, Stati Uniti, 77030-4009
- MD Anderson Cancer Center at University of Texas
-
Temple, Texas, Stati Uniti, 76508
- CCOP - Scott and White Hospital
-
-
Vermont
-
Burlington, Vermont, Stati Uniti, 05401
- Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus
-
-
Virginia
-
Charlottesville, Virginia, Stati Uniti, 22908
- Cancer Center at the University of Virginia
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98109-1024
- Fred Hutchinson Cancer Research Center
-
Tacoma, Washington, Stati Uniti, 98405
- MultiCare Regional Cancer Center at Tacoma General Hospital
-
-
Wisconsin
-
Madison, Wisconsin, Stati Uniti, 53792-6188
- University of Wisconsin Comprehensive Cancer Center
-
Marshfield, Wisconsin, Stati Uniti, 54449
- CCOP - Marshfield Clinic Research Foundation
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
DISEASE CHARACTERISTICS:
Histologically confirmed endometrial carcinoma
- Recurrent or persistent disease
- Refractory to curative or standard therapy
Measurable disease
- At least 1 unidimensionally measurable lesion ≥ 20 mm by conventional techniques OR ≥ 10 mm by spiral CT scan
At least 1 target lesion
- Tumors within a previously irradiated field are not considered target lesions
Received 1 prior chemotherapy regimen for endometrial carcinoma, including high-dose, consolidation, or extended therapy administered after surgical or non-surgical assessment
- One additional non-cytotoxic regimen for recurrent or persistent disease allowed, including monoclonal antibodies, cytokines, and small-molecule inhibitors of signal transduction
- Ineligible for a higher priority GOG protocol
PATIENT CHARACTERISTICS:
Age
- Any age
Performance status
- GOG 0-2
Life expectancy
- Not specified
Hematopoietic
- Absolute neutrophil count ≥ 1,500/mm^3
- Platelet count ≥ 100,000/mm^3
Hepatic
- SGOT ≤ 2.5 times upper limit of normal (ULN)
- Alkaline phosphatase ≤ 2.5 times ULN
- Bilirubin ≤ 1.5 times ULN
Renal
- Creatinine ≤ 1.5 times ULN
Other
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
- No neuropathy (sensory and motor) ≥ grade 2
- No active infection requiring antibiotics
- No other invasive malignancy within the past 5 years except nonmelanoma skin cancer
PRIOR CONCURRENT THERAPY:
Biologic therapy
- See Disease Characteristics
- At least 3 weeks since prior biologic or immunologic therapy for malignant tumor
- No concurrent prophylactic growth factors
- No concurrent prophylactic thrombopoietic agents
Chemotherapy
- See Disease Characteristics
- Recovered from prior chemotherapy
- No more than 1 prior cytotoxic chemotherapy regimen (single or combination cytotoxic drugs)
Endocrine therapy
- At least 1 week since prior hormonal therapy for malignant tumor
- Concurrent hormone replacement therapy allowed
Radiotherapy
- See Disease Characteristics
- Recovered from prior radiotherapy
Surgery
- Recovered from prior surgery
Other
- At least 3 weeks since other prior therapy for malignant tumor
- No prior anticancer therapy that would preclude current protocol therapy
- No concurrent amifostine or other protective reagents
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Mascheramento: Nessuno (etichetta aperta)
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Cattedra di studio: Agustin Garcia, MD, Premiere Oncology
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Neoplasie per tipo istologico
- Neoplasie
- Neoplasie urogenitali
- Neoplasie per sede
- Neoplasie, ghiandolari ed epiteliali
- Neoplasie uterine
- Neoplasie genitali, femmina
- Malattie uterine
- Carcinoma
- Neoplasie endometriali
- Meccanismi molecolari dell'azione farmacologica
- Agenti antineoplastici
- Modulatori della tubulina
- Agenti antimitotici
- Modulatori della mitosi
- Docetaxel
Altri numeri di identificazione dello studio
- GOG-0129N
- CDR0000368634
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Tumore endometriale
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletatoAdenocarcinoma dell'intestino tenue | Adenocarcinoma dell'intestino tenue in stadio III AJCC v8 | Adenocarcinoma dell'intestino tenue in stadio IIIA AJCC v8 | Adenocarcinoma dell'intestino tenue in stadio IIIB AJCC v8 | Adenocarcinoma dell'intestino tenue stadio IV AJCC v8 | Ampolla di Vater... e altre condizioniStati Uniti
-
Georgetown UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.; Susan G. Komen...CompletatoStudio delle donne cinesi che non hanno aderito alle linee guida per lo screening mammografico dell'American Cancer SocietyStati Uniti
-
National Cancer Institute (NCI)ReclutamentoKita-kyushu Lung Cancer Antigen 1, umanoStati Uniti
-
Novartis PharmaceuticalsReclutamentoEGFR mutante avanzato Non SmallSellLung Cancer (NSCLC), KRAS G12-mutant NSCLC, Esophageal SquamousCell Cancer (SCC), Head/Neck SCC, MelanomaOlanda, Corea, Repubblica di, Spagna, Taiwan, Giappone, Italia, Canada, Stati Uniti, Singapore
-
Emory UniversityNational Cancer Institute (NCI)RitiratoCancro al seno in stadio IV prognostico AJCC v8 | Neoplasia maligna metastatica nel cervello | Carcinoma mammario metastatico | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
NRG OncologyNational Cancer Institute (NCI)Attivo, non reclutanteCancro al seno in stadio anatomico IV AJCC v8 | Cancro al seno in stadio IV prognostico AJCC v8 | Neoplasia maligna metastatica nell'osso | Neoplasia maligna metastatica nei linfonodi | Neoplasia maligna metastatica nel fegato | Carcinoma mammario metastatico | Neoplasia maligna metastatica nel... e altre condizioniStati Uniti, Canada, Arabia Saudita, Corea, Repubblica di
-
Rashmi Verma, MDNational Cancer Institute (NCI)ReclutamentoCarcinoma prostatico resistente alla castrazione | Adenocarcinoma prostatico metastatico | Stadio IVB Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Jonsson Comprehensive Cancer CenterNon ancora reclutamentoCarcinoma della prostata | Stadio IVB Cancro alla prostata American Joint Committee on Cancer (AJCC) v8Stati Uniti
-
Assiut UniversityNon ancora reclutamentoDeterminare l’incidenza cumulativa di AKI utilizzando i criteri KDIGO in pazienti pediatrici con tumori maligni presso il South Egypt Cancer Institute (SECI)
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Attivo, non reclutanteStadio III Adenocarcinoma della prostata AJCC v7 | Stadio II Adenocarcinoma prostatico AJCC v7 | Fase I Adenocarcinoma della prostata American Joint Committee on Cancer (AJCC) v7Stati Uniti
Prove cliniche su docetaxel
-
Nereus Pharmaceuticals, Inc.CompletatoCancroStati Uniti, Australia, India, Chile, Brasile, Argentina
-
Tianjin Medical University Cancer Institute and...Reclutamento
-
Optimal Health ResearchCompletatoCancro al seno | Cancro ai polmoni | Cancro alla prostataStati Uniti
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, ChinaCompletatoCarcinoma polmonare non a piccole cellule (NSCLC)Cina
-
National Cancer Center, KoreaSeoul National University Bundang Hospital; Gachon University Gil Medical Center e altri collaboratoriSconosciutoTumore gastricoCorea, Repubblica di
-
Zhuhai Beihai Biotech Co., LtdCompletatoTumori solidi | Bioequivalenza | DocetaxelIndia
-
Arog Pharmaceuticals, Inc.RitiratoCarcinoma, polmone non a piccole cellule
-
SanofiCompletatoNeoplasie polmonariFrancia, Olanda, Spagna, Tacchino, Belgio, Finlandia, Italia, Regno Unito
-
SanofiCompletatoNeoplasie della testa e del colloFrancia
-
Fudan UniversityNon ancora reclutamentoCarcinoma polmonare avanzato non a piccole cellule